Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor

Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor

Indoxyl sulfate (IS) is a chronic kidney disease (CKD)-specific renal osteodystrophy metabolite that affects the nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), a transcription factor promoting osteoclastogenesis. However, the mechanisms underlying the regulation of NFATc1 by IS remain...

Full description

Bibliographic Details
Main Authors:	Wen-Chih Liu, Jia-Fwu Shyu, Paik Seong Lim, Te-Chao Fang, Chien-Lin Lu, Cai-Mei Zheng, Yi-Chou Hou, Chia-Chao Wu, Yuh-Feng Lin, Kuo-Cheng Lu
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	aryl hydrocarbon receptor indoxyl sulfate osteoclast chronic kidney disease NFATc1
Online Access:	https://www.mdpi.com/1422-0067/21/10/3486

Similar Items

Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
by: Jia-Fwu Shyu, et al.
Published: (2021-10-01)

Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway
by: Wen-Chih Liu, et al.
Published: (2020-10-01)

Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells
by: Guillaume Lano, et al.
Published: (2020-03-01)

Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings
by: Cindy Nguyen, et al.
Published: (2022-01-01)

Indoxyl Sulfate, a Uremic Endotheliotoxin
by: Guillaume Lano, et al.
Published: (2020-04-01)

Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway
by: Nada H. Eisa, et al.
Published: (2020-10-01)

Transcriptome Profiling Reveals Indoxyl Sulfate Should Be Culpable of Impaired T Cell Function in Chronic Kidney Disease
by: Fangfang Xiang, et al.
Published: (2020-05-01)

Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated
by: Takuya Wakamatsu, et al.
Published: (2018-03-01)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
by: Gang Wang, et al.
Published: (2022-01-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1
by: Yufeng Zhang, et al.
Published: (2022-05-01)

Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation
by: Xiaoxiao Li, et al.
Published: (2015-07-01)

Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD)
by: Hee Young Kim, et al.
Published: (2020-09-01)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01)

TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage
by: Chien-Lin Lu, et al.
Published: (2020-08-01)

Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
by: Jianbo He, et al.
Published: (2023-12-01)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
by: Yunfei Zhan, et al.
Published: (2020-01-01)

Inhibition of Human Osteoclast Differentiation by Kynurenine through the Aryl-Hydrocarbon Receptor Pathway
by: So-Yeon Kim, et al.
Published: (2021-12-01)

Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
by: Sheldon C. Leong, et al.
Published: (2016-11-01)

Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat
by: Ka-Yeon Lee, et al.
Published: (2019-08-01)

Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
by: Hiroshi Kishimoto, et al.
Published: (2023-02-01)

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
by: Huanhuan Hou, et al.
Published: (2020-02-01)

Involvement of PU.1 in NFATc1 promoter function in osteoclast development
by: Kentaro Ishiyama, et al.
Published: (2015-07-01)

-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
by: Hye Sun Hyun, et al.
Published: (2013-04-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Polycyclic Aromatic Hydrocarbons Affect Rheumatoid Arthritis Pathogenesis via Aryl Hydrocarbon Receptor
by: Xiaoyu Xi, et al.
Published: (2022-03-01)

Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
by: Chien-Lin Lu, et al.
Published: (2021-06-01)

Water Extracts of Hull-less Waxy Barley (<i>Hordeum vulgare</i> L.) Cultivar ‘Boseokchal’ Inhibit RANKL-induced Osteoclastogenesis
by: Kwang-Jin Kim, et al.
Published: (2019-10-01)

Indoxyl Sulfate Induces Oxidative Changes in Plasma and Hemolysate
by: Anna Pieniazek, et al.
Published: (2022-06-01)

Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways
by: Xiao Chen, et al.
Published: (2018-12-01)

NFATC1 and NFATC2 expression patterns in human osteochondromas
by: Yuanyuan Wang, et al.
Published: (2023-01-01)

Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos
by: Kazuma Yasuda, et al.
Published: (2021-12-01)

Tryptophan intake, not always the more the better
by: Dongmei Hu, et al.
Published: (2023-04-01)

Quantitative changes in indoxyl sulfate in chronic kidney disease
by: V.S. Vasylchenko
Published: (2022-05-01)

Indoxyl Sulfate Levels and Its Relation with Executive Function in Routine Hemodialysis Patients
by: Yuliarni Syafrita, et al.
Published: (2023-08-01)

Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
by: Lidia Ibáñez, et al.
Published: (2022-08-01)

Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer
by: Tiziana Guarnieri
Published: (2020-07-01)

Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets
by: Hao Zheng, et al.
Published: (2024-02-01)

Indoxyl sulfate is associated with mortality after AKI – more evidence needed!
by: Steven Menez, et al.
Published: (2019-07-01)

Aryl hydrocarbon receptor controls regulatory CD4+T cell function
by: Caroline Pot
Published: (2012-05-01)